Organisation Overview

The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. Spanning from translational to large, prospective, multi-centre, phase III clinical trials that evaluate new therapies and treatment strategies as well as patient quality of life, its activities are coordinated from EORTC Headquarters, a unique international clinical research infrastructure, based in Brussels, Belgium.

Our Mission

Improving cancer Patient Survival and Quality of Life – at the heart of EORTC’s research, since 1962.

Our Impact

Enabling and Delivering on Practice-Changing Clinical Cancer Research since 1962.

Annual Report

EORTC Annual Report 2023 - Cover

Annual Report 2023

 
EORTC Annual Report 2022 - Cover

Annual Report 2022

 
Annual Report 2021 - Cover

Annual Report 2021

 

Annual Report 2020

 

EORTC Leadership Team

Denis Lacombe - Chief Executive Officer

EORTC CEO

Denis Lacombe

 
Vassilis Golfinopoulos

HEADQUARTERS DIRECTOR

Vassilis Golfinopoulos

 
Jan Bogaerts

SCIENTIFIC DIRECTOR

Jan Bogaerts

 
Christian Brunet

CHIEF FINANCIAL OFFICER

Christian Brunet

 

PROJECTS DIRECTOR

Pascale Baltus

 

Latest EORTC Press Releases

  • SISAQOL-IMI: Setting standards for the use of patient-reported outcome data in cancer trials

    1 Jun 2023

  • EORTC QLG proudly collaborates on the EUonQoL project

    21 Mar 2023

  • EORTC: Working towards “Closing the Care Gap”

    2 Feb 2023

  • First EORTC anal cancer-specific questionnaire validated

    18 Nov 2022

EORTC in the News/Press

Article Press
Is Life-Saving Treatment Access for Rare Cancers a Game of Chance in Europe? Integrative Cancer Therapies
Here’s How Artificial Intelligence Can Help Predict Breast Cancer Risk Forbes
Enhancing cancer patient lives through cancer treatment optimisation HealthEuropa.com
Improving the lives of cancer patients Health Europa Quarterly (p. 170-173)
European cancer coalition led by EORTC calls for ‘Treatment Optimization’ to become an EU-wide parameter in novel cancer therapies development to improve outcomes in cancer treatment. Pharmiweb.com
New order: European cancer coalition calls for cancer PharmaTimes
European cancer coalition led by EORTC calls for ‘Treatment Optimization’ to become an EU-wide parameter in novel cancer therapies development to improve outcomes in cancer treatment. PF Media
How to ensure rare cancers get the attention they deserve World Economic Forum
Exclusive: Meet the New Head of Europe’s Formidable Cancer Non-Profit Applied Clinical Trials
EORTC and Alliance Healthcare’s continued partnership in support of SPECTA clinical research infrastructure Pharmiweb.com

EORTC Media Assets

Showcase the EORTC with the right logos and assets:

EORTC Style Guide including our logos.

EORTC profile

The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. Spanning from translational to large, prospective, multi-centre, phase III clinical trials that evaluate new therapies and treatment strategies as well as patient quality of life, its activities are coordinated from EORTC Headquarters, a unique international clinical research infrastructure, based in Brussels, Belgium.

For further information, please visit www.eortc.org.

EORTC Imagery

EORTC Building

EORTC HQ building Brussels

 
EORTC Building

EORTC HQ building Brussels

 

Media Relations Contact Information

Our Communications team loves working with journalists to share compelling stories about cancer research and care. If you are a member of the media and would like to reach out, please send an email to communication@eortc.org.